BALPHARMA.NSBALPHARMA.NSNSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P21
Within normal range
vs 3Y Ago
-1.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-7.77%
202421.07%
202318.81%
20226.07%
2021638.33%
2020-122.32%
201910.47%
201836.90%
2017-3.59%
2016-22.68%